Ruth is an experienced pre-clinical executive with versatile scientific experience and a distinguished track record in chemistry, biology, and oncology research. She is currently Pre-Clinical Manager with aVISI Ltd., a clinical stage startup developing ocular therapies. In her role, Ruth is leading pre-clinical research and shaping the company's pipeline through significant contributions at the intersection of science and healthcare.Previously, Ruth was Medical Science Liaison in a global pharmaceutical company, and a study director with Pharmaseed, an innovative Clinical Research Organization. Ruth holds a PhD from the Weizmann Institute of Science, and enriched by post-doctoral fellowships at the esteemed institutions Harvard Medical School and Arizona State University.